Surmodics Inc (NAS:SRDX)
$ 39.67 -0.01 (-0.03%) Market Cap: 567.05 Mil Enterprise Value: 560.32 Mil PE Ratio: 0 PB Ratio: 4.78 GF Score: 70/100

Surmodics Inc at Jefferies Healthcare Conference Transcript

Jun 04, 2019 / 02:30PM GMT
Release Date Price: $41.84 (+3.98%)
Raj Denhoy
Jefferies LLC - Analyst

Thanks, everyone, for joining us here at the Jefferies 2019 healthcare conference. I'm Raj Denhoy with the medical device research team. Up next we have Surmodics and from the company we have Tim Arens, the Company's CFO, and Gary Maharaj, the Company's CEO. And Gary, I'll turn it over to you.

Gary Maharaj
Surmodics, Inc. - President & CEO

Thanks, Raj. Bring your attention to the [interim] risks and uncertainties in many of the forward-looking statements all make today. I'll just jump to the punch line ---- many of you know Surmodics, we are a technology company that really is heavily invested in R&D. And we have some major bold visions for the future, as you can see here. But really what I want to go to is really our three portfolios.

And on the left there you see what we're trying to accomplish clinically. On the right you see the three major areas that we're investing in in R&D. And firstly we have ---- and we always think of platforms, not products. So we have a drug delivery platform that has some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot